SCHEMBL20962001

SCHEMBL20962001

COc1cccc(-c2cc3c4ccccc4c(-c4ccc(O)c(C(=O)c5ccccc5)c4)cc3c3ccccc23)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
LMNA P02545 3/20 0.52
HPGD P15428 3/20 0.52
HTT P42858 2/20 0.52
CYP1A2 P05177 1/20 0.52
PGR P06401 1/20 0.52
CYP2D6 P10635 1/20 0.52
SLC6A2 P23975 1/20 0.52
PDE4A P27815 1/20 0.52
MAPK1 P28482 1/20 0.52
CYP2C19 P33261 1/20 0.52
HRH1 P35367 1/20 0.52
SLC6A3 Q01959 1/20 0.52
PDE4D Q08499 1/20 0.52
KDM4E B2RXH2 2/20 0.49
MAPT P10636 2/20 0.49
HSD17B10 Q99714 2/20 0.49
CYP3A4 P08684 1/20 0.49
RECQL P46063 1/20 0.49
CYP2C8 P10632 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20962003 0.88 HPGD (0.54) ALDH1A1LMNAHPGDHTTCYP1A2
SCHEMBL20961992 0.87 BRD4 (0.45) ALDH1A1LMNAHPGDCYP1A2PGR
SCHEMBL20961994 0.86 GSTA1 (0.53) ALDH1A1LMNAHPGDKDM4EMAPT
SCHEMBL20968012 0.84 MAPT (0.55) ALDH1A1LMNAHPGDHTTCYP1A2
SCHEMBL20961998 0.80 MCL1 (0.64) LMNAHPGDKDM4EMAPTHSD17B10
SCHEMBL3902536 0.78 LMNA (0.77) ALDH1A1LMNAHPGDHTTCYP1A2
SCHEMBL20968004 0.74 MCL1 (0.51) ALDH1A1LMNAHPGDKDM4EMAPT
SCHEMBL28023333 0.74 KMT2A (0.61) MAPTCYP2C8RAB9AKMT2AGAA
SCHEMBL2790754 0.74 SERPINE1 (0.54) ALDH1A1LMNAHPGDHTTCYP2D6
SCHEMBL10621564 0.73 GSTA1 (0.74) LMNAHPGDKDM4EMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800791-B2 Light absorber and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-24 US disclosed
US-11800791-B2 Light absorber and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-24 US disclosed
EP-3477722-B1 LIGHT ABSORBER AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2023-09-27 EP disclosed
US-20220037592-A1 LIGHT ABSORBER AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-02-03 US disclosed
US-11158809-B2 Light absorber and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-10-26 US disclosed
US-20210143360-A1 DISPLAY DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-05-13 US disclosed
US-20190131532-A1 LIGHT ABSORBER AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-05-02 US disclosed
EP-3477722-A1 LIGHT ABSORBER AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME Samsung Display Co., Ltd. (KR) 2019-05-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11158809-B2 Light absorber and organic electroluminescence device including the same CRY2, CRY1, AHR ALDH1A1 129/4885LMNA 1125/4885HPGD 860/4885
US-20210143360-A1 DISPLAY DEVICE DDR1, SDC4, SDC1 ALDH1A1 388/4885LMNA 3907/4885HPGD 4143/4885
US-11800791-B2 Light absorber and organic electroluminescence device including the same CRY2, CRY1, AHR ALDH1A1 129/4885LMNA 1125/4885HPGD 860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.